UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006518
Receipt No. R000007731
Scientific Title Phase II study of erlotinib in advanced or recurrent EGFR mutation positive Non-small cell lung cancer patients who were previously treated with intrapleural therapy for malignant pleural effusion.
Date of disclosure of the study information 2011/10/12
Last modified on 2011/10/11 16:22:19

No. Disposal Last modified on Item of update
1 Insert 2011/10/11 16:23:41


Contact us.